JP2010536333A5 - - Google Patents

Download PDF

Info

Publication number
JP2010536333A5
JP2010536333A5 JP2010520628A JP2010520628A JP2010536333A5 JP 2010536333 A5 JP2010536333 A5 JP 2010536333A5 JP 2010520628 A JP2010520628 A JP 2010520628A JP 2010520628 A JP2010520628 A JP 2010520628A JP 2010536333 A5 JP2010536333 A5 JP 2010536333A5
Authority
JP
Japan
Prior art keywords
polypeptide
seq
iii
composition
amino acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010520628A
Other languages
English (en)
Japanese (ja)
Other versions
JP5697447B2 (ja
JP2010536333A (ja
Filing date
Publication date
Priority claimed from GB0715949A external-priority patent/GB0715949D0/en
Priority claimed from GB0716224A external-priority patent/GB0716224D0/en
Priority claimed from GB0723337A external-priority patent/GB0723337D0/en
Application filed filed Critical
Priority claimed from PCT/GB2008/002780 external-priority patent/WO2009022156A2/en
Publication of JP2010536333A publication Critical patent/JP2010536333A/ja
Publication of JP2010536333A5 publication Critical patent/JP2010536333A5/ja
Application granted granted Critical
Publication of JP5697447B2 publication Critical patent/JP5697447B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010520628A 2007-08-15 2008-08-15 アレルゲンに対する脱感作のためのペプチド Expired - Fee Related JP5697447B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB0715949.4 2007-08-15
GB0715949A GB0715949D0 (en) 2007-08-15 2007-08-15 Peptide with improved solubility
GB0716224.1 2007-08-20
GB0716224A GB0716224D0 (en) 2007-08-20 2007-08-20 Peptides for vaccine
GB0723337.2 2007-11-28
GB0723337A GB0723337D0 (en) 2007-11-28 2007-11-28 Peptide with reduced dimer formation
PCT/GB2008/002780 WO2009022156A2 (en) 2007-08-15 2008-08-15 Peptides for desensibilization against allergens

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014204979A Division JP6040207B2 (ja) 2007-08-15 2014-10-03 アレルゲンに対する脱感作のためのペプチド

Publications (3)

Publication Number Publication Date
JP2010536333A JP2010536333A (ja) 2010-12-02
JP2010536333A5 true JP2010536333A5 (OSRAM) 2011-09-29
JP5697447B2 JP5697447B2 (ja) 2015-04-08

Family

ID=40134075

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2010520628A Expired - Fee Related JP5697447B2 (ja) 2007-08-15 2008-08-15 アレルゲンに対する脱感作のためのペプチド
JP2014204979A Expired - Fee Related JP6040207B2 (ja) 2007-08-15 2014-10-03 アレルゲンに対する脱感作のためのペプチド
JP2016191563A Pending JP2017061455A (ja) 2007-08-15 2016-09-29 アレルゲンに対する脱感作のためのペプチド

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2014204979A Expired - Fee Related JP6040207B2 (ja) 2007-08-15 2014-10-03 アレルゲンに対する脱感作のためのペプチド
JP2016191563A Pending JP2017061455A (ja) 2007-08-15 2016-09-29 アレルゲンに対する脱感作のためのペプチド

Country Status (23)

Country Link
US (7) US8551493B2 (OSRAM)
EP (4) EP2083856B1 (OSRAM)
JP (3) JP5697447B2 (OSRAM)
KR (1) KR101699554B1 (OSRAM)
CN (2) CN101820907B (OSRAM)
AT (1) ATE482721T1 (OSRAM)
AU (1) AU2008288283B2 (OSRAM)
BR (1) BRPI0815395A2 (OSRAM)
CA (1) CA2696563A1 (OSRAM)
CY (2) CY1110981T1 (OSRAM)
DE (1) DE602008002810D1 (OSRAM)
DK (2) DK2083856T3 (OSRAM)
EA (2) EA023303B1 (OSRAM)
ES (1) ES2402956T3 (OSRAM)
HR (2) HRP20100662T1 (OSRAM)
IL (1) IL203943A (OSRAM)
MX (1) MX2010001779A (OSRAM)
NZ (2) NZ583361A (OSRAM)
PL (1) PL2083856T3 (OSRAM)
PT (2) PT2083856E (OSRAM)
SI (2) SI2190473T1 (OSRAM)
WO (4) WO2009022155A2 (OSRAM)
ZA (2) ZA201001056B (OSRAM)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0710529D0 (en) 2007-06-01 2007-07-11 Circassia Ltd Vaccine
SI2190473T1 (sl) 2007-08-15 2013-05-31 Circassia Limited Peptid z zmanjšano tvorbo dimerov
ATE536880T1 (de) 2008-08-15 2011-12-15 Circassia Ltd Impfstoff beinhaltend amb a 1 peptide zur behandlung von traubenkraut-allergie
US8821887B2 (en) 2008-08-15 2014-09-02 Circassia Limited T-cell antigen peptide from allergen for stimulation of IL-10 production
GB0821806D0 (en) * 2008-11-28 2009-01-07 Circassia Ltd Compositions with reduced dimer formation
WO2010089554A1 (en) * 2009-02-05 2010-08-12 Circassia Limited Peptides for vaccine
WO2011043538A2 (ko) * 2009-10-08 2011-04-14 주식회사이언메딕스 실내 공기유래 세포밖 소포체를 포함하는 조성물 및 이의 용도
EP3170510A1 (de) * 2010-01-14 2017-05-24 Merck Patent GmbH Varianten der gruppe 5-allergene der süssgräser mit reduzierter allergenität durch mutagenese von prolinresten
GB201002559D0 (en) * 2010-02-15 2010-03-31 Circassia Ltd Birch peptides for vaccine
AU2011260233C1 (en) * 2010-06-03 2015-04-16 Alk-Abello A/S Pharmaceutical product comprising mite allergen extract(s) and a method for the manufacture thereof
DK2619219T3 (en) * 2010-09-24 2016-02-22 Maria R Diaz-Torres Peptides
EP2460824A1 (en) * 2010-12-01 2012-06-06 Biomay Ag Hypoallergenic polypeptides for the treatment of house dust mite allergy
CN103501812A (zh) 2011-04-29 2014-01-08 西莱克塔生物科技公司 用于过敏症治疗的致耐受性合成纳米载体
CA2838888A1 (en) * 2011-06-15 2012-12-20 Biotech Tools S.A. A method for the production of hydrolyzed allergens
US20130039954A1 (en) 2011-07-29 2013-02-14 Selecta Biosciences, Inc. Control of antibody responses to synthetic nanocarriers
GB201208293D0 (en) * 2012-05-11 2012-06-20 Circassia Ltd Hydrochlorice salt of peptide
GB201209868D0 (en) * 2012-06-01 2012-07-18 Circassia Ltd Alternaria peptides
GB201209862D0 (en) 2012-06-01 2012-07-18 Circassia Ltd Cladosporium peptides
CN105120894B (zh) 2012-10-30 2019-02-15 阿拉沃克斯有限公司 新颖的免疫治疗分子和其用途
CN118370823A (zh) 2013-05-03 2024-07-23 西莱克塔生物科技公司 用于降低的或增强的药效学作用的致耐受性合成纳米载体和治疗性大分子
US20160130311A1 (en) * 2013-06-05 2016-05-12 Maria R. Diaz-Torres T cell epitopes derived from alt a 1 or alt a 5 for the treatment of alternaria alternata allergy
CA2914037A1 (en) * 2013-06-06 2014-12-11 Anergis S.A. Contiguous overlapping peptides for treatment of house dust mites allergy
JP7007534B2 (ja) * 2013-09-25 2022-01-24 アラヴァックス ピーティーワイ リミテッド 新規免疫療法組成物およびその使用
US10059751B2 (en) * 2013-12-23 2018-08-28 Alk-Abelló A/S Peptide combinations and uses thereof in treating dust mite allergy
KR20160138283A (ko) 2014-03-31 2016-12-02 베링거잉겔하임베트메디카게엠베하 개선된 모듈러 항원 운반 분자 및 이의 용도
WO2016037162A1 (en) 2014-09-07 2016-03-10 Selecta Biosciences, Inc. Methods and compositions for attenuating anti-viral transfer vector immune responses
US10149904B2 (en) 2015-02-20 2018-12-11 The Board Of Trusteees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10166286B2 (en) 2015-02-20 2019-01-01 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10143742B2 (en) 2015-02-20 2018-12-04 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US11452774B2 (en) 2015-02-20 2022-09-27 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
CN107735408A (zh) * 2015-03-30 2018-02-23 国立大学法人大阪大学 免疫用肽、免疫用肽的制备方法、包含其的免疫疾病用医药组合物及免疫疾病的治疗方法
EA201890856A1 (ru) * 2015-09-30 2018-10-31 Бёрингер Ингельхайм Ветмедика Гмбх Улучшенные транспортные молекулы модулярного антигена и их применение у животных
KR101858840B1 (ko) 2016-01-15 2018-05-16 단국대학교 천안캠퍼스 산학협력단 집먼지진드기 유래 알레르겐에 의한 과민반응 면역조절제
HUE072005T2 (hu) 2017-03-11 2025-10-28 Cartesian Therapeutics Inc Gyulladásgátlókkal és immunszupresszánst tartalmazó szintetikus nanohordozókkal történõ kombinált kezeléssel összefüggõ eljárások és készítmények
SG11202000419QA (en) 2017-07-18 2020-02-27 Before Brands Inc Methods for making mixed allergen compositions
MA50265A (fr) * 2017-09-18 2020-07-29 Sutro Biopharma Inc Conjugués anticorps-récepteur alpha anti-folate et leurs utilisations
CN108078891B (zh) * 2017-12-28 2021-05-07 昆明赛诺制药股份有限公司 一种含美洲大蠊精提物的保湿修复洗面奶
CN107970199B (zh) * 2018-01-03 2021-05-07 昆明赛诺制药股份有限公司 一种含美洲大蠊精提物的牙膏
SG11202108043PA (en) 2019-01-23 2021-08-30 Before Brands Inc Methods for making mixed allergen compositions
CN117362453B (zh) * 2023-12-08 2024-02-27 山东硕景生物科技有限公司 一种Derf1重组抗原、其制备方法及应用

Family Cites Families (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0044532B1 (en) 1980-07-18 1986-04-23 E.I. Du Pont De Nemours And Company Monothioglycerol as thiol-protector in lyophilized materials
US4442212A (en) * 1980-11-10 1984-04-10 E. I. Du Pont De Nemours & Company Monothioglycerol as thiol-protector in lyophilized materials
US5126399A (en) 1986-04-30 1992-06-30 Board Of Regents, The University Of Texas System Methods and compositions for the preparation and use of site-directed immunologic reagents
US4906564A (en) 1987-03-13 1990-03-06 The United States Of America As Represented By The Secretary Of The Army Antigenic determinants recognized by antibodies obtained using a pathogenic agent or a derivative thereof that presents a restricted set of antigens
EP0362290A4 (en) * 1987-06-17 1991-09-25 Princess Margaret Children's Medical Research Foundation (Inc.) Cloning of mite allergens
FI891226L (fi) 1988-04-28 1989-10-29 Univ Leland Stanford Junior Reseptordeterminanter i anti-t-celler foer behandling av autoimmunsjukdom.
GB8812214D0 (en) 1988-05-24 1988-06-29 Hoffmann La Roche Use of peptide from circumsporozoite protein of p falciparum as universally recognized t-cell epitope
ES2013359A6 (es) 1988-11-04 1990-05-01 Corporacion Biolog Farmaceutic Procedimiento para la fabricacion de alergenos inmunogenicos polimerizados.
CA1340977C (en) 1988-11-15 2000-04-25 Monty Krieger Scavenger receptor protein and antibody thereto
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5399346A (en) 1989-06-14 1995-03-21 The United States Of America As Represented By The Department Of Health And Human Services Gene therapy
US5547669A (en) * 1989-11-03 1996-08-20 Immulogic Pharma Corp Recombinant peptides comprising T cell epitopes of the cat allergen, Fel d I
DK0500785T3 (da) 1989-11-03 2002-08-19 Immulogic Pharma Corp Humant T-celleaktivitet felint protein (TRFP) isoleret fra husstøv samt anvendelser heraf
US6019972A (en) * 1989-11-03 2000-02-01 Immulogic Pharmaceutical Corporation Peptides of human T cell reactive feline protein (TRFP)
US5433948A (en) * 1990-02-13 1995-07-18 Thomas; Wayne R. Cloning and sequencing of allergens of dermatophagoides (house dust mite)
JP3592709B2 (ja) * 1990-09-11 2004-11-24 インスティテュート・フォー・チャイルド・ヘルス・リサーチ ダーマトファゴイデス（家塵ダニ）のアレルゲンのクローニングおよびシークエンシング
US5593698A (en) 1990-10-31 1997-01-14 Autoimmune, Inc. Suppression of proliferative response and induction of tolerance with polymorphic class II MHC allopeptides
JP2632603B2 (ja) 1991-03-12 1997-07-23 アサヒビール株式会社 ヒト抗ＤｅｒｆＩＩＩｇＥ抗体が結合するペプチド
US6982326B1 (en) 1991-07-12 2006-01-03 Immulogic Pharmaceutical Corporation Allergenic proteins and peptides from Japanese cedar pollen
US6555116B1 (en) * 1991-10-12 2003-04-29 Regents Of The University Of California Alleviation of the allergenic potential of airborne and contact allergens by thioredoxin
WO1994024281A1 (en) 1993-04-14 1994-10-27 Immulogic Pharmaceutical Corporation T cell epitopes of the major allergens from dermatophagoides (house dust mite)
EP0623168B1 (en) 1991-10-16 2009-09-30 Merck Patent GmbH T cell epitopes of the major allergens from dermatophagoides (house dust mite)
US7288256B1 (en) * 1991-10-16 2007-10-30 Merck Patent Gmbh T cell epitopes of the major allergens from dermatophagoides (house dust mite)
US6696061B1 (en) 1992-08-11 2004-02-24 President And Fellows Of Harvard College Immunomodulatory peptides
WO1994004572A1 (fr) 1992-08-14 1994-03-03 Torii & Co., Ltd. Peptide allergene
US5939283A (en) * 1992-12-31 1999-08-17 Immulogic Pharmaceutical Corporation Allergenic proteins and peptides from dog dander and uses therefor
US5697103A (en) 1993-01-11 1997-12-16 Personal Expression I, Inc. Therapeutic glove
WO1994021675A2 (en) 1993-03-12 1994-09-29 Immulogic Pharmaceutical Corporation T cell epitopes of ryegrass pollen allergen
US6849427B1 (en) * 1993-03-12 2005-02-01 Immulogic Pharmaceutical Corp. Nucleic acids encoding a house dust mite allergen, Der p VII, and uses therefor
KR960701995A (ko) * 1993-04-14 1996-03-28 스테이시 엘. 채닝 더마토파고이드즈(집 먼지 진드기)로부터의 주요 알레르겐의 t세포 에피토프(t.cells epitopes of the major allergens from dermatophagoids(house dust mite))
AU674584B2 (en) 1993-06-02 1997-01-02 Tvw Telethon Institute For Child Health Research Cryptic peptides for use in inducing immunologic tolerance
JPH09504167A (ja) 1993-08-13 1997-04-28 イミュロジック ファーマスーティカル コーポレイション ドクムギ花粉アレルゲンのｔ細胞エピトープ
US6180771B1 (en) * 1993-12-08 2001-01-30 Immulogic Pharmaceutical Corp. Nucleic acids encoding a house dust mite allergen, Der p III, and uses therefor
JPH07215996A (ja) 1994-01-31 1995-08-15 Torii Yakuhin Kk ダニアレルゲンのｂ細胞エピトープ
US5820862A (en) * 1994-04-14 1998-10-13 Immulogic Pharmaceutical Corporation T cell epitopes of the major allergens from dermatophagoides (house dust mite)
PT755407E (pt) * 1994-04-14 2007-07-20 Merck Patent Gmbh Formulações farmacêuticas à base de péptidos para tratamento de alergia aos ácaros do pó
US6759234B1 (en) * 1994-09-02 2004-07-06 Immulogic Pharmaceutical Corporation Compositions and methods for administering to humans, peptides capable of down regulating an antigen specific immune response
IL115744A (en) 1994-10-27 2000-07-16 Akzo Nobel Nv Peptides comprising a subsequence of human cartilage glycoprotein - 39
DE19508192A1 (de) * 1995-03-09 1996-09-12 Behringwerke Ag Stabile Transglutaminasepräparate und Verfahren zu ihrer Herstellung
DE19545662C2 (de) * 1995-12-07 1998-11-26 Mannesmann Sachs Ag Selbstpumpendes hydropneumatisches Federbein mit innerer Niveauregulierung
DE69739062D1 (de) 1996-03-21 2008-12-04 Circassia Ltd Verwendung von kryptischen Peptiden zur Induktion von immunologischer Toleranz
US6238888B1 (en) 1997-12-22 2001-05-29 Human Genone Sciences, Inc. Keratinocyte growth factor-2 formulations
JP2002500198A (ja) 1998-01-09 2002-01-08 サーカシア リミテッド 脱感作のための方法及び組成物
FR2806727A1 (fr) 2000-03-23 2001-09-28 Pf Medicament Molecule d'interet pharmaceutique comprotant en son extremite n-terminale un acide glutamique ou une glutamine sous forme de sel d'addition d'acide fort physiologiquement acceptable
DK1731912T3 (da) 2000-08-21 2014-01-06 Apitope Technology Bristol Ltd Fremgangmåde til peptidselektion
WO2002017956A2 (en) * 2000-08-31 2002-03-07 Chiron Corporation Stabilized fgf formulations containing reducing agents
DE60136653D1 (de) * 2000-11-16 2009-01-02 Alk Abello As Mutante allergene
US7786257B2 (en) 2000-12-18 2010-08-31 University Of Kansas Signal-1/signal-2 bifunctional peptide inhibitors
US7320793B2 (en) 2001-01-19 2008-01-22 Cytos Biotechnology Ag Molecular antigen array
FR2820425B1 (fr) 2001-02-08 2004-01-02 Commissariat Energie Atomique Melange de peptides issus d'une proteine nef et leurs applications
JP4812951B2 (ja) * 2001-03-21 2011-11-09 一般財団法人化学及血清療法研究所 特異性不明のｔ細胞のクローン化法及びその認識ペプチドリガンドの同定方法
GB0108752D0 (en) * 2001-04-06 2001-05-30 Isis Innovation Peptide epitopes and uses thereof
AU2002305138A1 (en) * 2001-04-09 2002-10-21 Mayo Foundation For Medical Education And Research Methods and materials for cancer treatment
AUPR775401A0 (en) 2001-09-18 2001-10-11 Monash University Novel Epitopes and Uses Thereof
JP2005521640A (ja) 2001-11-13 2005-07-21 ジェネンテック・インコーポレーテッド Ａｐｏ−２リガンド／ＴＲＡＩＬ製剤
ES2316632T3 (es) * 2001-12-05 2009-04-16 Circassia Limited Metodos y sistemas inmunoterapeuticos.
AUPS148202A0 (en) 2002-04-02 2002-05-09 Monash University Immunotherapeutic and immunoprophylactic reagents
FR2841906B1 (fr) 2002-07-05 2006-08-18 Stallergenes Sa Molecule d'acide nucleique codant une preproproteine d'allergene d'un acarien du genre dermatophagoides ou euroglyphus et son utilisation pour la production dudit allergene dans les plantes
CN102061288A (zh) 2002-07-17 2011-05-18 希托斯生物技术股份公司 使用衍生自ap205外壳蛋白的病毒样颗粒的分子抗原阵列
US20040071718A1 (en) * 2002-09-18 2004-04-15 Jaw-Ji Tsai Local nasal immunotherapy for allergen-induced airway inflammation
US8198401B2 (en) 2003-03-07 2012-06-12 London Health Sciences Centre Research Inc. Peptides associated with HLA-DR MHC class II molecule and involved in rheumatoid arthritis
ATE368687T1 (de) 2003-06-26 2007-08-15 Merck Patent Gmbh Thrombopoietinproteine mit verbesserten eigenschaften
GB0315754D0 (en) * 2003-07-04 2003-08-13 Univ Aberdeen Pharmaceutical compositions
US20050053615A1 (en) * 2003-07-16 2005-03-10 Best Elaine A. Variants of mite group 1 allergens for the treatment of house dust mite allergy
CA2545458A1 (en) 2003-11-10 2005-05-26 Arriva-Prometic Inc. Dry recombinant human alpha 1-antitrypsin formulation
EP1756150A2 (en) 2004-04-23 2007-02-28 Novozymes A/S Group 1 mite polypeptide variants
WO2005121166A1 (en) 2004-06-10 2005-12-22 Monash University Novel immunointeractive molecules and uses thereof
US20060029551A1 (en) 2004-08-05 2006-02-09 Kui Liu Stable particle formulations of erythropoietin receptor agonists
WO2006035725A1 (ja) 2004-09-27 2006-04-06 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo イソサイクロマルトオリゴ糖及びイソサイクロマルトオリゴ糖生成酵素とそれらの製造方法並びに用途
CA2596255A1 (en) 2005-02-01 2006-08-10 Attenuon, Llc Compositions containing the anti-angiogenic phscn-peptide
FR2881746B1 (fr) 2005-02-07 2007-04-13 Centre Nat Rech Scient Epitopes t cd4+des antigenes de latence de type i et ii du virus epstein-barr aptes a etre reconnus par la majorite des individus de la population caucasienne et leurs applications
PL1931998T3 (pl) 2005-09-15 2010-11-30 Alk Abello As Sposób ilościowego oznaczania alergenów
EP1829895A1 (en) 2006-03-03 2007-09-05 f-star Biotechnologische Forschungs- und Entwicklungsges.m.b.H. Bispecific molecule binding TLR9 and CD32 and comprising a T cell epitope for treatment of allergies
GB0609121D0 (en) * 2006-05-09 2006-06-21 Univ Birmingham Peptide Therapy
AT503690A1 (de) * 2006-06-09 2007-12-15 Biomay Ag Hypoallergene moleküle
ES2657504T3 (es) * 2006-08-11 2018-03-05 Life Sciences Research Partners Vzw Péptidos inmunogénicos y su uso en trastornos inmunitarios
EP1958645A1 (en) 2007-02-13 2008-08-20 Biomay AG Peptides derived from the major allergen of ragweed (Ambrosia artemisiifolia) and uses thereof
WO2008115428A2 (en) 2007-03-16 2008-09-25 The Board Of Trustees Of The Leland Stanford Junior University A scaleable manufacturing process for cysteine endoprotease b, isoform 2
GB0710529D0 (en) 2007-06-01 2007-07-11 Circassia Ltd Vaccine
SI2190473T1 (sl) 2007-08-15 2013-05-31 Circassia Limited Peptid z zmanjšano tvorbo dimerov
WO2009067191A2 (en) * 2007-11-16 2009-05-28 The General Hospital Corporation Methods and compositions for the treatment of hepatitis c virus (hcv) infection
GB2455108A (en) 2007-11-28 2009-06-03 Circassia Ltd T-Cell dependent method for detecting non-allergic or intrinsic disorders

Similar Documents

Publication Publication Date Title
JP2010536333A5 (OSRAM)
CN105451755B (zh) 铁调素类似物和其用途
HRP20100662T1 (hr) Peptidi za desenzibilizaciju protiv alergena
KR101593158B1 (ko) Ｎ-말단이 변형된 포도당 의존적인 인슐린 분비 자극성 폴리펩타이드(ｇｉｐ)의 유사체
KR101593155B1 (ko) 포도당 의존적인 인슐린 분비 자극성 폴리펩타이드 유사체
TWI653980B (zh) 治療及預防缺血性傷害之組成物與方法
HRP20120206T4 (hr) Cjepivo koje sadrži amb a 1 peptide za uporabu u lijeäśenju alergije na ambroziju
KR20110043686A (ko) 포도당 의존적인 인슐린 분비 자극성 폴리펩타이드의 유사체
JP2013543497A5 (OSRAM)
KR20150021072A (ko) 성장 호르몬 결핍의 치료에 있어서 hgh-xten 융합 단백질 및 이의 용도
JP2012516693A5 (OSRAM)
JP6811190B2 (ja) プロテアーゼ耐性脂質付加ｇｌｐ−１類似体
CN104271596A (zh) 肽激素的降钙素cgrp家族的肽拮抗剂和它们的用途
KR20160098406A (ko) 프로테아제 내성 펩티드
KR20190017017A (ko) 프로테아제-내성 모노-지질화된 펩타이드
CN118946367A (zh) 嵌合多肽
CN118891059A (zh) 嵌合多肽
TW200716166A (en) Lawsonia intracellularis immunological proteins
JP2005082489A6 (ja) 新規な摂食促進ペプチド、新規な成長ホルモン分泌促進ペプチド
JP2005082489A (ja) 新規な摂食促進ペプチド、新規な成長ホルモン分泌促進ペプチド
AU2018275270B2 (en) Peptide PAC1 antagonists
JP2009520772A5 (OSRAM)
JP2013529600A5 (OSRAM)
NZ749740A (en) Escalating dosage schedules for treating celiac disease
JPWO2022155704A5 (OSRAM)